These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 16631123

  • 1. Expression analysis and prognostic significance of the SRA1 gene, in ovarian cancer.
    Leoutsakou T, Talieri M, Scorilas A.
    Biochem Biophys Res Commun; 2006 Jun 02; 344(2):667-74. PubMed ID: 16631123
    [Abstract] [Full Text] [Related]

  • 2. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
    Yousef GM, Kyriakopoulou LG, Scorilas A, Fracchioli S, Ghiringhello B, Zarghooni M, Chang A, Diamandis M, Giardina G, Hartwick WJ, Richiardi G, Massobrio M, Diamandis EP, Katsaros D.
    Cancer Res; 2001 Nov 01; 61(21):7811-8. PubMed ID: 11691797
    [Abstract] [Full Text] [Related]

  • 3. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer.
    Kim H, Scorilas A, Katsaros D, Yousef GM, Massobrio M, Fracchioli S, Piccinno R, Gordini G, Diamandis EP.
    Br J Cancer; 2001 Mar 02; 84(5):643-50. PubMed ID: 11237385
    [Abstract] [Full Text] [Related]

  • 4. Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer.
    Borgoño CA, Kishi T, Scorilas A, Harbeck N, Dorn J, Schmalfeldt B, Schmitt M, Diamandis EP.
    Clin Cancer Res; 2006 Mar 01; 12(5):1487-93. PubMed ID: 16533772
    [Abstract] [Full Text] [Related]

  • 5. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
    Lu L, Katsaros D, Wiley A, de la Longrais IA, Puopolo M, Yu H.
    Cancer Invest; 2008 Mar 01; 26(2):185-92. PubMed ID: 18259951
    [Abstract] [Full Text] [Related]

  • 6. SR-A1, a member of the human pre-mRNA splicing factor family, and its expression in colon cancer progression.
    Mathioudaki K, Leotsakou T, Papadokostopoulou A, Paraskevas E, Ardavanis A, Talieri M, Scorilas A.
    Biol Chem; 2004 Sep 01; 385(9):785-90. PubMed ID: 15493872
    [Abstract] [Full Text] [Related]

  • 7. Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker.
    Scorilas A, Borgoño CA, Harbeck N, Dorn J, Schmalfeldt B, Schmitt M, Diamandis EP.
    J Clin Oncol; 2004 Feb 15; 22(4):678-85. PubMed ID: 14966091
    [Abstract] [Full Text] [Related]

  • 8. Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients.
    Obiezu CV, Scorilas A, Katsaros D, Massobrio M, Yousef GM, Fracchioli S, Rigault de la Longrais IA, Arisio R, Diamandis EP.
    Clin Cancer Res; 2001 Aug 15; 7(8):2380-6. PubMed ID: 11489816
    [Abstract] [Full Text] [Related]

  • 9. Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer.
    Scorilas A, Kyriakopoulou L, Katsaros D, Diamandis EP.
    Br J Cancer; 2001 Jul 20; 85(2):190-8. PubMed ID: 11461075
    [Abstract] [Full Text] [Related]

  • 10. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer.
    Castellvi J, Garcia A, Rojo F, Ruiz-Marcellan C, Gil A, Baselga J, Ramon y Cajal S.
    Cancer; 2006 Oct 15; 107(8):1801-11. PubMed ID: 16983702
    [Abstract] [Full Text] [Related]

  • 11. The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas.
    Han L, Dong Z, Qiao Y, Kristensen GB, Holm R, Nesland JM, Suo Z.
    Gynecol Oncol; 2005 Nov 15; 99(2):278-86. PubMed ID: 16061279
    [Abstract] [Full Text] [Related]

  • 12. Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression.
    Koensgen D, Mustea A, Klaman I, Sun P, Zafrakas M, Lichtenegger W, Denkert C, Dahl E, Sehouli J.
    Gynecol Oncol; 2007 Nov 15; 107(2):266-73. PubMed ID: 17698176
    [Abstract] [Full Text] [Related]

  • 13. Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients.
    Mezzanzanica D, Fabbi M, Bagnoli M, Staurengo S, Losa M, Balladore E, Alberti P, Lusa L, Ditto A, Ferrini S, Pierotti MA, Barbareschi M, Pilotti S, Canevari S.
    Clin Cancer Res; 2008 Mar 15; 14(6):1726-33. PubMed ID: 18347173
    [Abstract] [Full Text] [Related]

  • 14. Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells.
    Okamoto A, Nikaido T, Ochiai K, Takakura S, Saito M, Aoki Y, Ishii N, Yanaihara N, Yamada K, Takikawa O, Kawaguchi R, Isonishi S, Tanaka T, Urashima M.
    Clin Cancer Res; 2005 Aug 15; 11(16):6030-9. PubMed ID: 16115948
    [Abstract] [Full Text] [Related]

  • 15. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
    Bignotti E, Tassi RA, Calza S, Ravaggi A, Romani C, Rossi E, Falchetti M, Odicino FE, Pecorelli S, Santin AD.
    Gynecol Oncol; 2006 Nov 15; 103(2):405-16. PubMed ID: 16725184
    [Abstract] [Full Text] [Related]

  • 16. LAPTM4B overexpression is an independent prognostic marker in ovarian carcinoma.
    Yang Y, Yang H, McNutt MA, Xiong F, Nie X, Li L, Zhou R.
    Oncol Rep; 2008 Nov 15; 20(5):1077-83. PubMed ID: 18949404
    [Abstract] [Full Text] [Related]

  • 17. The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer.
    Brennan DJ, Ek S, Doyle E, Drew T, Foley M, Flannelly G, O'Connor DP, Gallagher WM, Kilpinen S, Kallioniemi OP, Jirstrom K, O'Herlihy C, Borrebaeck CA.
    Eur J Cancer; 2009 May 15; 45(8):1510-7. PubMed ID: 19272768
    [Abstract] [Full Text] [Related]

  • 18. Reduced bikunin gene expression as a factor of poor prognosis in ovarian carcinoma.
    Tanaka Y, Kobayashi H, Suzuki M, Kanayama N, Suzuki M, Yamakawa T, Morishita H, Terao T.
    Cancer; 2003 Jul 15; 98(2):424-30. PubMed ID: 12872365
    [Abstract] [Full Text] [Related]

  • 19. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.
    Liu HB, Kong CZ, Zeng Y, Liu XK, Bi JB, Jiang YJ, Han S.
    Urol Oncol; 2009 Jul 15; 27(3):277-83. PubMed ID: 18555709
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of the human kallikrein gene 15 expression in ovarian cancer.
    Yousef GM, Scorilas A, Katsaros D, Fracchioli S, Iskander L, Borgono C, Rigault de la Longrais IA, Puopolo M, Massobrio M, Diamandis EP.
    J Clin Oncol; 2003 Aug 15; 21(16):3119-26. PubMed ID: 12915603
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.